Celontin Capsule
Product Images NDC 0071-0525

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Celontin (NDC 0071-0525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Celontin 01)

Chemical structure of methsuximide, the active ingredient in Celontin capsules 300 mg. The diagram shows the molecular arrangement of methsuximide including its bonds and ring structures.*

FDA Label Image

Company Logo (Celontin 02)

FDA Label Image

Principal Display Panel (300 mg Capsule Bottle Label)

Celontin 300 mg capsules, oral, containing methsuximide, distributed by Parke-Davis Division of Pfizer Inc. The label includes storage instructions, dosage warnings, and a package count of 100 capsules. The product NDC is 0071-0525-24. Additional identifiers include lot number, expiration date, serial number, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.